DSM-Firmenich (DSFIR) Stock Overview
Provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
DSFIR Community Fair Values
Create NarrativeSee what 48 others think this stock is worth. Follow their fair value or set your own to get alerts.
An Undervalued 3.3Moz Gold Project in Canada
Key takeaways Upside Gold is developing the Kena Gold Project, near the town of Nelson in the Kootenays region of southern British Columbia. Kena hosts a historical gold resource of 3.33 million ounces (561,000 ounces Indicated and 2.77 million ounces Inferred) across a 10,200-hectare land package.Read more
DSM-Firmenich AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €62.62 |
| 52 Week High | €99.92 |
| 52 Week Low | €55.22 |
| Beta | 0.52 |
| 1 Month Change | 12.99% |
| 3 Month Change | -7.64% |
| 1 Year Change | -27.59% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -46.82% |
Recent News & Updates
Recent updates
DSM-Firmenich AG's (AMS:DSFIR) Shareholders Might Be Looking For Exit
Nov 26
Is It Time To Consider Buying DSM-Firmenich AG (AMS:DSFIR)?
Oct 19DSM-Firmenich (AMS:DSFIR) Has A Pretty Healthy Balance Sheet
Sep 28The DSM-Firmenich AG (AMS:DSFIR) Half-Yearly Results Are Out And Analysts Have Published New Forecasts
Aug 05DSM-Firmenich AG (AMS:DSFIR) Shares Could Be 40% Below Their Intrinsic Value Estimate
Aug 02Is It Too Late To Consider Buying DSM-Firmenich AG (AMS:DSFIR)?
Jul 11Pinning Down DSM-Firmenich AG's (AMS:DSFIR) P/S Is Difficult Right Now
Jun 15Does DSM-Firmenich (AMS:DSFIR) Have A Healthy Balance Sheet?
Apr 25
Focusing On Taste, Texture, And Health Will Strengthen Future Prospects
The merger of DSM and Firmenich focuses on high-growth segments, enhancing revenue through synergies and achieving significant earnings improvements.Shareholder Returns
| DSFIR | NL Chemicals | NL Market | |
|---|---|---|---|
| 7D | 2.0% | 3.5% | 5.6% |
| 1Y | -27.6% | -20.3% | 41.9% |
Return vs Industry: DSFIR underperformed the Dutch Chemicals industry which returned -21.5% over the past year.
Return vs Market: DSFIR underperformed the Dutch Market which returned 40% over the past year.
Price Volatility
| DSFIR volatility | |
|---|---|
| DSFIR Average Weekly Movement | 4.9% |
| Chemicals Industry Average Movement | 4.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in NL Market | 8.0% |
| 10% least volatile stocks in NL Market | 2.9% |
Stable Share Price: DSFIR has not had significant price volatility in the past 3 months compared to the Dutch market.
Volatility Over Time: DSFIR's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1902 | 26,873 | Dimitri de Vreeze | www.dsm-firmenich.com |
DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients.
DSM-Firmenich AG Fundamentals Summary
| DSFIR fundamental statistics | |
|---|---|
| Market cap | €15.69b |
| Earnings (TTM) | €274.00m |
| Revenue (TTM) | €9.03b |
Is DSFIR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DSFIR income statement (TTM) | |
|---|---|
| Revenue | €9.03b |
| Cost of Revenue | €5.50b |
| Gross Profit | €3.53b |
| Other Expenses | €3.26b |
| Earnings | €274.00m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
Jul 30, 2026
| Earnings per share (EPS) | 1.09 |
| Gross Margin | 39.07% |
| Net Profit Margin | 3.03% |
| Debt/Equity Ratio | 26.1% |
How did DSFIR perform over the long term?
See historical performance and comparisonDividends
Does DSFIR pay a reliable dividends?
See DSFIR dividend history and benchmarks| DSM-Firmenich dividend dates | |
|---|---|
| Ex Dividend Date | May 11 2026 |
| Dividend Pay Date | May 19 2026 |
| Days until Ex dividend | 29 days |
| Days until Dividend pay date | 37 days |
Does DSFIR pay a reliable dividends?
See DSFIR dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/10 18:36 |
| End of Day Share Price | 2026/04/10 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
DSM-Firmenich AG is covered by 41 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jennifer Barker | Barclays |
| Alexander Sloane | Barclays |
| Sebastian Bray | Berenberg |